11 Oct 2022 – EyRIS is excited to announce that SELENA+, our artificial intelligence deep learning system has received regulatory approval from the Thai Food and Drug Administration (FDA). We cannot wait for the deployment of our product in Thailand and stand ready to join their fight against diabetes.
Diabetes is an exploding epidemic throughout the world. Thailand has certainly not been spared, having over 6 million diabetic patients today and expected to hit 7 million before the end of the decade. Our product can aid healthcare professionals to detect and prioritize treatment for diabetes-related eye diseases.
SELENA+ is EyRIS’ artificial intelligence deep learning system with the ability to detect 3 diseases: diabetic retinopathy, glaucoma suspect, and age-related macular degeneration.
Please direct all queries related to this article to Marketing at firstname.lastname@example.org
Comments are closed.